BKS Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BKS Advisors's LLY Position: Q1 2019 in Review
BKS Advisors reduced its Eli Lilly (LLY) stake by 0.23% in Q1 2019, selling an estimated $10.3K and leaving 37,608 shares worth $4.88M. The position accounts for 1.96% of the portfolio, ranked #8.
BKS Advisors first reported a position in LLY in Q1 2015 and has held it in 17 quarters since. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.
- BKS Advisors held 37,608 shares of Eli Lilly worth $4.88M as of Q1 2019.
- BKS Advisors sold 85 Eli Lilly shares in Q1 2019, an estimated $10.3K.
- Eli Lilly made up 1.96% of BKS Advisors's portfolio in Q1 2019, its #8 holding.
- BKS Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 17 quarters since.
- 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.
Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.